Review article: defining remission in ulcerative colitis

Review article: medication non-adherence in ulcerative colitis - strategies to improve adherence with mesalazine and other maintenance therapies

(2010) A. B. HAWTHORNE et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

(2010) Asher Kornbluth et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Treatment of ulcerative colitis from the patient’s perspective: a survey of preferences and satisfaction with therapy

(2009) J. R. GRAY et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Mesalamine Once Daily Is More Effective Than Twice Daily in Patients With Quiescent Ulcerative Colitis

(2009) Axel U. Dignass et al.   Clinical Gastroenterology and Hepatology

Patient reported symptoms during an ulcerative colitis flare: A Qualitative Focus Group Study

(2009) Akbar K. Waljee et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

(2009) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

Importance of mucosal healing in ulcerative colitis

(2009) Gary R. Lichtenstein et al.   INFLAMMATORY BOWEL DISEASES

World Gastroenterology Organization Practice Guidelines for the Diagnosis and Management of IBD in 2010

(2009) Charles N. Bernstein et al.   INFLAMMATORY BOWEL DISEASES

5-ASA in ulcerative colitis: Improving treatment compliance

(2009) Cosimo Prantera et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Systematic review: impact of non-adherence to 5-aminosalicylic acid products on the frequency and cost of ulcerative colitis flares

(2008) P. D. R. HIGGINS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Home Telemanagement for Patients with Ulcerative Colitis (UC HAT)

(2008) Raymond K. Cross et al.   DIGESTIVE DISEASES AND SCIENCES

Once daily versus three times daily mesalazine granules in active ulcerative colitis: a double-blind, double-dummy, randomised, non-inferiority trial

(2008) W Kruis et al.   GUT

Randomised trial of once- or twice-daily MMX mesalazine for maintenance of remission in ulcerative colitis

(2008) M A Kamm et al.   GUT

Identification of symptom domains in ulcerative colitis that occur frequently during flares and are responsive to changes in disease activity

(2008) Joel C Joyce et al.   Health and Quality of Life Outcomes

Endoscopic healing should be a goal for everyone with ulcerative colitis

(2008) Sunanda Kane   INFLAMMATORY BOWEL DISEASES

Effect of extended MMX mesalamine therapy for acute, mild-to-moderate Ulcerative Colitis

(2008) Michael A. Kamm et al.   INFLAMMATORY BOWEL DISEASES

Impact of ulcerative colitis from patientsʼ and physiciansʼ perspectives

(2008) David T. Rubin et al.   INFLAMMATORY BOWEL DISEASES

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis

(2008) E.F. Stange et al.   Journal of Crohns & Colitis

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY